• 1. An intermolecular C–C coupling reaction of iridium complexes?
  Kathrin Kutlescha,Rhett Kempe New J. Chem., 2010,34, 1954-1960
• 2. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 3. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 4. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 5. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Methoxybenzoic acids and derivatives

Introduction to 2-Amino-3-bromo-6-methoxybenzoic acid (CAS No. 1240480-64-1)

2-Amino-3-bromo-6-methoxybenzoic acid, identified by its Chemical Abstracts Service (CAS) number 1240480-64-1, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and medicinal chemistry. This benzoic acid derivative features a unique structural motif, combining an amino group, a bromine substituent, and a methoxy group on a benzene ring, which endows it with distinct chemical and biological properties. The compound's unique arrangement of functional groups makes it a valuable intermediate in the synthesis of various pharmacologically active molecules.

The significance of 2-Amino-3-bromo-6-methoxybenzoic acid lies in its potential applications as a building block for the development of novel therapeutic agents. In recent years, there has been a growing interest in designing molecules that can modulate biological pathways associated with inflammation, cancer, and neurodegenerative diseases. The benzoic acid scaffold is particularly well-studied for its role in drug design due to its stability and versatility in forming hydrogen bonds, which are crucial for molecular recognition processes.

One of the most compelling aspects of 2-Amino-3-bromo-6-methoxybenzoic acid is its role in the synthesis of inhibitors targeting enzyme-catalyzed reactions. The bromine atom at the 3-position enhances electrophilicity, making it susceptible to nucleophilic substitution reactions, which are pivotal in constructing more complex molecules. Similarly, the methoxy group at the 6-position influences electronic distribution across the aromatic ring, affecting reactivity and binding affinity. These features make it an attractive candidate for further derivatization to create high-affinity ligands for protein targets.

Recent advancements in computational chemistry have enabled researchers to predict the binding modes of 2-Amino-3-bromo-6-methoxybenzoic acid derivatives with various biomacromolecules. Molecular docking studies have suggested that this compound can interact with enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX), which are key players in inflammatory responses. By modulating the activity of these enzymes, derivatives of 2-Amino-3-bromo-6-methoxybenzoic acid could potentially serve as anti-inflammatory agents.

In addition to its pharmacological relevance, 2-Amino-3-bromo-6-methoxybenzoic acid has shown promise in material science applications. Its ability to form stable complexes with metal ions makes it useful in designing metal-organic frameworks (MOFs) and coordination polymers. These materials have diverse applications, including gas storage, catalysis, and sensing technologies. The bromine substituent further enhances its utility in such applications by facilitating coordination interactions with transition metals.

The synthesis of 2-Amino-3-bromo-6-methoxybenzoic acid typically involves multi-step organic transformations starting from commercially available benzoic acid derivatives. Key steps include bromination at the 3-position followed by methoxylation at the 6-position, often employing palladium-catalyzed cross-coupling reactions for precision and efficiency. Advances in green chemistry have also led to the development of more sustainable synthetic routes, minimizing waste and reducing reliance on hazardous reagents.

The biological activity of 2-Amino-3-bromo-6-methoxybenzoic acid has been explored through both in vitro and in vivo studies. Initial pharmacokinetic assessments have revealed favorable solubility and metabolic stability, suggesting its potential for further development into a drug candidate. Preclinical trials have demonstrated that certain derivatives exhibit anti-proliferative effects on cancer cell lines by inhibiting key signaling pathways involved in tumor growth and metastasis.

The structural diversity offered by 2-Amino-3-bromo-6-methoxybenzoic acid allows for extensive chemical modification, enabling researchers to fine-tune its biological activity. For instance, replacing the amino group with other nitrogen-containing heterocycles can alter binding interactions with target proteins. Similarly, introducing additional functional groups such as carboxylic acids or esters can enhance solubility or bioavailability.

The growing body of research on 2-Amino-3-bromo-6-methoxybenzoic acid underscores its importance as a versatile intermediate in drug discovery and material science. As computational methods improve and synthetic techniques evolve, the potential applications of this compound are likely to expand further. Collaborative efforts between academic institutions and pharmaceutical companies will be crucial in translating these findings into tangible therapeutic benefits for patients worldwide.

In conclusion,2-Amino-3-bromo-6-methoxybenzoic acid (CAS No. 1240480-64-1) represents a promising chemical entity with broad utility across multiple disciplines. Its unique structural features make it an excellent candidate for designing novel drugs targeting various diseases while also serving as a valuable component in advanced materials. Continued investigation into its properties and potential applications will undoubtedly yield significant advancements in both chemistry and medicine.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)